Economic burden of resected squamous cell carcinoma of the head and neck in a US managed-care population

References

• Menzin J, Lines LM, Manning LN. The economics of squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2007;15:68-73
   PubMedGoogle Scholar
• Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30
   PubMed Web of Science ®Google Scholar
• American Cancer Society. Facts and Figures. 2010. Available at: http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-and-figures-2010. Last accessed April 15, 2011
   Google Scholar
• Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002;52:195-215
   PubMed Web of Science ®Google Scholar
• Vokes EE, Weichselbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med 1993;328:184-94
   PubMed Web of Science ®Google Scholar
• Lee JM, Turini M, Botterman MF, et al. Economic burden of head and neck cancer: a literature review. Eur J Health Econ 2004;5:70-80
   PubMedGoogle Scholar
• National Cancer Institute. Surveillance Epidemiology and End Results. Cancer of the larynx. Available at: http://seer.cancer.gov/csr/1975_2007/browse_csr.php?section=12&page=sect_12_table.08.html
   Google Scholar
• National Cancer Institute. Surveillance Epidemiology and End Results. Cancer of the larynx. Available at: http://seer.cancer.gov/csr/1975_2007/browse_csr.php?section=20&page=sect_20_table.10.html
   Google Scholar
• National Cancer Institute. Cancer Facts. Head and Neck Cancer: Questions and Answers. Available at: http://www.cancer.gov/cancertopics/factsheet/Sites-Types/head-and-neck Accessed April 4, 2011
   Google Scholar
• Wineland AM, Stack BC Jr. Modern methods to predict costs for the treatment and management of head and neck cancer patients: examples of methods used in the current literature. Curr Opin Otolaryngol Head Neck Surg 2008;16:113-16
   PubMedGoogle Scholar
• Arthur G James Cancer Hospital & Research Institute. The James Line: Head and Neck Cancers. Available at: http://www.jamesline.com/headandneck/. Accessed June 23, 2010
   Google Scholar
• Correa AJ, Burkey BB. Otolaryngology for the internist: current options in management of head and neck cancer patients. Med Clin North Am 1999;83:235-46
   PubMedGoogle Scholar
• Lester SE, Wigt RG. ‘When will I see you again?’ Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients. Clin Otolaryngol 2009;34:546-51
   PubMed Web of Science ®Google Scholar
• Dubner S, Ostrower ST. Head and neck cancer – resection and neck dissection: treatment. eMedicine Updated April 3, 2008
   Google Scholar
• Ang KK. Multidisciplinary management of locally advanced SCCHN: optimizing treatment outcomes. Oncologist 2008;13:899-910
   PubMed Web of Science ®Google Scholar
• Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010;11:21-8
   PubMed Web of Science ®Google Scholar
• Murphy BA, Beaumont JL, Isitt J, et al. Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. J Pain Symptom Manage 2009;38:522-32
   PubMedGoogle Scholar
• Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. IARC CancerBase no. 5. IARC: Lyon, 2001
   Google Scholar
• Jovanovic A, van der Tol IG, Schulten EA, et al. Risk of multiple primary tumors following oral squamous-cell carcinoma. Int J Cancer 1994;56:320-3
   PubMed Web of Science ®Google Scholar
• Posner MR. Adjuvant post-operative chemoradiotherapy in head and neck cancer: a standard of care? Oncologist 2005;10:174-5
   PubMedGoogle Scholar
• Posner MR. Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy. Oncologist 2005;10(Suppl 3):11-19
   PubMedGoogle Scholar
• Forastiere A, Koch W, Trotti A, et al. Head and neck cancer. N Engl J Med 2001;345:1890-900
   PubMed Web of Science ®Google Scholar
• Hall SF, Groome PA, Rothwell D. Time to first relapse as an outcome and a predictor of survival in patients with squamous cell carcinoma of the head and neck. Laryngoscope 2000;110:2041-6
   PubMedGoogle Scholar
• Groome PA, O’Sullivan B, Irish JC, et al. Glottic cancer in Ontario, Canada and the SEER areas of the United States: do different management philosophies produce different outcome profiles? J Clin Epidemiol 2001;54:301-15
   PubMedGoogle Scholar
• Epstein JP, Knight TK, Epstein JB, et al. Cost of care for early- and late-stage oral and pharyngeal cancer in the California Medicaid population. Head Neck 2007;29:948-58
   PubMedGoogle Scholar
• Nijdam W, Levendag P, Noever I, et al. Cost analysis comparing brachytherapy versus surgery for primary carcinoma of the tonsillar fossa and/or soft palate. Int J Radiat Oncol Biol Phys 2004;59:488-94
   PubMedGoogle Scholar
• Davis GE, Schwartz SR, Veenstra DL, et al. Cost comparison of surgery vs organ presentation for laryngeal cancer. Arch Otolaryngol Head Neck Surg 2005;131:21-6
   PubMedGoogle Scholar
• Hopper C, Niziol C, Sidhu M. The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. Oral Oncol 2004;40:372-82
   PubMed Web of Science ®Google Scholar
• Kosuda S, Kosuda S, Kusano S, et al. Feasibility and cost-effectiveness of sentinel lymph node radiolocalization in stage N0 head and neck cancer. Arch Otolaryngol Head Neck Surg 2003;129:1105-9
   PubMedGoogle Scholar
• Speight PM, Palmer S, Moles DR, et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess 2006;10:1-144
   PubMedGoogle Scholar
• Zavras A, Andrepoulous N, Katsikeris N, et al. Oral cancer treatment costs in Greece and the effect of advanced disease. BMC Public Health 2002;19:12
   Google Scholar
• Van Agthoven M, van Ineveld BM, de Boer MF, et al. The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. Eur J Cancer 2001;37:2204-11
   PubMedGoogle Scholar
• Lang K, Menzin J, Earle CC, et al. The economic cost of squamous cell cancer of the head and neck: findings from the SEER-Medicare data. Arch Otolaryngol Head Neck Surg 2004;130:1269-75
   PubMed Web of Science ®Google Scholar